Stiripentol
Stiripentol (STP) is an anticonvulsant agent that noncompetitively inhibits CYP3A4 and competitively inhibits CYP2C19, thereby reducing the N-demethylation of clobazam to N-desmethylclobazam. It is used in research on epilepsy, drug metabolism, and cytochrome P450 interactions, with applications in both in vitro enzyme assays and in vivo pharmacological studies.
Product Specifications
CAS Number
49763-96-4
Product Name Alternative
BCX 2600, BCX2600, BCX-2600, Diacomit, CYP2C19, CYP3A4, CYPs, Cytochrome P450, inhibit, Inhibitor, Stiripentol
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.87% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (21.34 mM) ; DMSO:250 mg/mL (1067.05 mM) ; Ethanol:30 mg/mL (128.05 mM)
Smiles
C (=CC (C (C) (C) C) O) C=1C=C2C (=CC1) OCO2
Molecular Formula
C14H18O3
Molecular Weight
234.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human CCL24/Eotaxin-2/MPIF-2 Protein, N-His
Anti-HIF-1 alpha/HIF1A Antibody Picoband® (Dylight488 Conjugate)